Elpro International Ltd — Important, 21-04-2026: Company Update

Elpro International has acquired an additional 1,33,086 equity shares of Cohance Lifesciences Limited for INR 4.79 Cr, increasing its total holding to 2,48,813 equity shares. This investment move strengthens Elpro's presence in the pharmaceuticals sector. Cohance Lifesciences operates in Pharma CDMO, APIs, Specialty Chemicals, and Formulations, reporting a consolidated turnover of 1,256.14 Cr for FY 2024-25, with operations in India and the USA. This strategic investment provides exposure to a diversified pharmaceutical business.